May 8, 2011

TWiPO host Dr. Tim Cripe and co-host Dr. Jim Geller discuss updates after two recent meetings and an exciting paper published on “Tumor regression in patients with metastatic synovial cell sarcoma and melanoma using genetically engineered lymphocytes reactive with NY-ESO-1” J Clin Oncol. 2011 Mar 1;29(7):917-24.

1:23 Conference on oncolytic viruses (see recent webinar on pediatric trials).

7:28 Conference on DIPG (Diffuse Intrinsic Pontine Glioma) at Cincinnati Children`s; discussion on biology, new tumor models, and genetic profiling.

12:50 Discussion on adoptive immunotherapy using tumor-infiltrating lymphocytes in patients with metastatic melanoma and synovial cell sarcoma.

28:28 Listener email questions and answers.

Please send questions and comments to

Leave a Comment